Inventor · disambiguated record
Jeremy Dale Waight
Also filed as: WAIGHT JEREMY · WAIGHT JEREMY D · WAIGHT JEREMY DALE
11 granted patents·13 pending applications·47 citations·filing 2016–2023
89Inventor score
Files withAGENUS INC24
Top patents by PatentIndex Score
24 records- 0197US10836830B2Antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Nov 17, 2020·12 cites·45 claims
- 0296US10639368B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2017·Granted May 5, 2020·15 cites·32 claims
- 0396US10626181B2Nucleic acids encoding anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Apr 21, 2020·7 cites·35 claims
- 0495US10912828B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Feb 9, 2021·4 cites·36 claims
- 0585US11692042B2Anti-CD73 antibodies and methods of use thereofAGENUS INC·Filed 2019·Granted Jul 4, 2023·3 cites·22 claims
- 0685US11472883B2Methods of administering anti-OX40 antibodiesAGENUS INC·Filed 2020·Granted Oct 18, 2022·1 cites·15 claims
- 0784US11447557B2Antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Sep 20, 2022·3 cites·46 claims
- 0884US11136404B2Anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Oct 5, 2021·1 cites·64 claims
- 0984US2023167186A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1084US2023108348A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1182US2024181048A1Anti-tim-3 antibodies and methods of use thereofAGENUS INC·Filed 2023·Application pending·0 cites
- 1280US11359028B2Anti-OX40 antibodies and anti-GITR antibodiesAGENUS INC·Filed 2019·Granted Jun 14, 2022·1 cites·16 claims
- 1380US2023406946A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1480US2023399413A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1579US2022098316A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 1675US12011481B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2021·Granted Jun 18, 2024·0 cites·28 claims
- 1773US2022389107A1Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1873US2022380479A1Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1972US2021171648A1Antibodies and methods of use thereofAGENUS INC·Filed 2020·Application pending·0 cites
- 2071US11839653B2Anti-TIM-3 antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Dec 12, 2023·0 cites·25 claims
- 2170US2023416397A1Anti-cd73 antibodies and methods of use thereofAGENUS INC·Filed 2023·Application pending·0 cites
- 2267US2021324097A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 2355US2020079862A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2016·Application pending·0 cites
- 2441US2020123265A1Anti-gitr antibodies and methods of use thereofAGENUS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeremy Dale Waight files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →